$STML Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in STEMLINE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in STEMLINE THERAPEUTICS INC. Get notifications about new insider transactions in STEMLINE THERAPEUTICS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Option Exercise | D | 4.12 | 45,102 | 185,820 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | U | 0.00 | 327,878 | 0 | 0 | 327.9 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 45,000 | 0 | 327,878 | 282.9 K to 327.9 K (+15.91 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Sard Mark | Director | Sell | U | 0.00 | 51,468 | 0 | 0 | 51.5 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | HUME DANIEL | Director | Sell | U | 0.00 | 35,468 | 0 | 0 | 35.5 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 4.12 | 356,700 | 1,469,604 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 3.30 | 180,704 | 596,323 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 2.92 | 90,352 | 263,828 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | U | 0.00 | 3,024,336 | 0 | 0 | 3 M to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 220,000 | 0 | 3,024,336 | 2.8 M to 3 M (+7.84 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Option Exercise | D | 8.20 | 24,000 | 196,800 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Option Exercise | D | 6.78 | 34,000 | 230,520 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Option Exercise | D | 3.30 | 18,070 | 59,631 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Option Exercise | D | 2.92 | 9,034 | 26,379 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Sell | U | 0.00 | 66,346 | 0 | 0 | 66.3 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Option Exercise | D | 4.12 | 44,058 | 181,519 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Option Exercise | D | 5.77 | 25,000 | 144,250 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | U | 0.00 | 1,374,352 | 0 | 0 | 1.4 M to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 600,000 | 0 | 1,374,352 | 774.4 K to 1.4 M (+77.48 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Option Exercise | D | 9.79 | 50,000 | 489,500 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | U | 0.00 | 200,891 | 0 | 0 | 200.9 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Cline Darren S | Director | Sell | U | 0.00 | 35,468 | 0 | 0 | 35.5 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Option Exercise | D | 8.20 | 24,000 | 196,800 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Option Exercise | D | 6.78 | 34,000 | 230,520 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Sell | U | 0.00 | 88,298 | 0 | 0 | 88.3 K to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Option Exercise | D | 8.20 | 24,000 | 196,800 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Option Exercise | D | 6.78 | 34,000 | 230,520 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Sell | U | 0.00 | 60,121 | 0 | 0 | 60.1 K to 0 (-100.00 %) |
| May 06 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 11.51 | 272 | 3,131 | 197,658 | 197.9 K to 197.7 K (-0.14 %) |
| Apr 20 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 4.88 | 53,618 | 261,656 | 2,804,336 | 2.9 M to 2.8 M (-1.88 %) |
| Apr 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.79 | 11,524 | 55,200 | 282,878 | 294.4 K to 282.9 K (-3.91 %) |
| Mar 20 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 3.88 | 2,849 | 11,054 | 316,885 | 319.7 K to 316.9 K (-0.89 %) |
| Mar 20 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 3.88 | 2,849 | 11,054 | 316,885 | 319.7 K to 316.9 K (-0.89 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 4.91 | 16,704 | 82,017 | 771,764 | 788.5 K to 771.8 K (-2.12 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 5.08 | 9,487 | 48,194 | 788,468 | 798 K to 788.5 K (-1.19 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 5.00 | 1,266 | 6,330 | 197,930 | 199.2 K to 197.9 K (-0.64 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 4.92 | 36,542 | 179,787 | 2,857,954 | 2.9 M to 2.9 M (-1.26 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 5.09 | 20,909 | 106,427 | 2,894,496 | 2.9 M to 2.9 M (-0.72 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 4.92 | 8,846 | 43,522 | 319,734 | 328.6 K to 319.7 K (-2.69 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 5.08 | 5,011 | 25,456 | 328,580 | 333.6 K to 328.6 K (-1.50 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 6.42 | 11,547 | 74,132 | 797,955 | 809.5 K to 798 K (-1.43 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 6.43 | 9,147 | 58,815 | 333,591 | 342.7 K to 333.6 K (-2.67 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 6.42 | 11,547 | 74,132 | 797,955 | 809.5 K to 798 K (-1.43 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 208,417 | 0 | 809,502 | 601.1 K to 809.5 K (+34.67 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 208,417 | 0 | 809,502 | 601.1 K to 809.5 K (+34.67 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Grant | A | 0.00 | 105,939 | 0 | 199,196 | 93.3 K to 199.2 K (+113.60 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Grant | A | 0.00 | 105,939 | 0 | 199,196 | 93.3 K to 199.2 K (+113.60 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 6.72 | 5,064 | 34,030 | 93,257 | 98.3 K to 93.3 K (-5.15 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 6.72 | 5,064 | 34,030 | 93,257 | 98.3 K to 93.3 K (-5.15 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 107,317 | 0 | 342,738 | 235.4 K to 342.7 K (+45.59 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |
| Jan 24 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 7.02 | 22,139 | 155,416 | 601,085 | 623.2 K to 601.1 K (-3.55 %) |
| Jan 10 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.37 | 13,228 | 137,174 | 623,224 | 636.5 K to 623.2 K (-2.08 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.48 | 2,022 | 21,191 | 636,452 | 638.5 K to 636.5 K (-0.32 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.75 | 15,494 | 166,561 | 638,474 | 654 K to 638.5 K (-2.37 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.97 | 24,477 | 268,513 | 653,968 | 678.4 K to 654 K (-3.61 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.58 | 4,319 | 45,695 | 678,445 | 682.8 K to 678.4 K (-0.63 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.48 | 197 | 2,065 | 235,421 | 235.6 K to 235.4 K (-0.08 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.75 | 1,511 | 16,243 | 235,618 | 237.1 K to 235.6 K (-0.64 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.97 | 2,388 | 26,196 | 237,129 | 239.5 K to 237.1 K (-1.00 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 10.58 | 421 | 4,454 | 239,517 | 239.9 K to 239.5 K (-0.18 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.48 | 2,446 | 25,634 | 2,514,773 | 2.5 M to 2.5 M (-0.10 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.75 | 18,744 | 201,498 | 2,517,219 | 2.5 M to 2.5 M (-0.74 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.97 | 29,613 | 324,855 | 2,535,963 | 2.6 M to 2.5 M (-1.15 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.58 | 5,225 | 55,281 | 2,565,576 | 2.6 M to 2.6 M (-0.20 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 10.48 | 116 | 1,216 | 98,321 | 98.4 K to 98.3 K (-0.12 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 10.75 | 893 | 9,600 | 98,437 | 99.3 K to 98.4 K (-0.90 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 10.97 | 1,412 | 15,490 | 99,330 | 100.7 K to 99.3 K (-1.40 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Francomano Robert | Chief Commercial Of ... | Sell | S | 10.58 | 249 | 2,634 | 100,742 | 101 K to 100.7 K (-0.25 %) |
| Dec 06 2019 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Buy | P | 9.73 | 1,000 | 9,730 | 88,298 | 87.3 K to 88.3 K (+1.15 %) |
| Dec 06 2019 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Buy | P | 9.73 | 1,000 | 9,730 | 88,298 | 87.3 K to 88.3 K (+1.15 %) |
| Dec 04 2019 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Buy | P | 10.29 | 1,000 | 10,290 | 87,298 | 86.3 K to 87.3 K (+1.16 %) |
| Aug 16 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 14.73 | 35,010 | 515,697 | 2,570,801 | 2.6 M to 2.6 M (-1.34 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 14.77 | 12,508 | 184,743 | 682,764 | 695.3 K to 682.8 K (-1.80 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 15.07 | 25,500 | 384,285 | 695,272 | 720.8 K to 695.3 K (-3.54 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 15.49 | 9,107 | 141,067 | 720,772 | 729.9 K to 720.8 K (-1.25 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 14.77 | 16,994 | 251,001 | 2,605,811 | 2.6 M to 2.6 M (-0.65 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 15.10 | 28,500 | 430,350 | 2,622,805 | 2.7 M to 2.6 M (-1.07 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 15.49 | 10,822 | 167,633 | 2,651,305 | 2.7 M to 2.7 M (-0.41 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | HUME DANIEL | Director | Grant | A | 0.00 | 15,000 | 0 | 35,468 | 20.5 K to 35.5 K (+73.29 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Cline Darren S | Director | Grant | A | 0.00 | 15,000 | 0 | 35,468 | 20.5 K to 35.5 K (+73.29 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Sard Mark | Director | Grant | A | 0.00 | 15,000 | 0 | 51,468 | 36.5 K to 51.5 K (+41.13 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Grant | A | 0.00 | 15,000 | 0 | 60,121 | 45.1 K to 60.1 K (+33.24 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Grant | A | 0.00 | 15,000 | 0 | 43,158 | 28.2 K to 43.2 K (+53.27 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Grant | A | 0.00 | 10,000 | 0 | 65,443 | 55.4 K to 65.4 K (+18.04 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Grant | A | 0.00 | 15,000 | 0 | 55,443 | 40.4 K to 55.4 K (+37.09 %) |
| May 17 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 15,000 | 0 | 239,938 | 224.9 K to 239.9 K (+6.67 %) |
| May 17 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 14.27 | 25,817 | 368,409 | 729,879 | 755.7 K to 729.9 K (-3.42 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.05 | 2,151 | 23,769 | 2,662,127 | 2.7 M to 2.7 M (-0.08 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.11 | 55,073 | 611,861 | 2,664,278 | 2.7 M to 2.7 M (-2.03 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 11.04 | 981 | 10,830 | 755,696 | 756.7 K to 755.7 K (-0.13 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 11.11 | 25,101 | 278,872 | 756,677 | 781.8 K to 756.7 K (-3.21 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.05 | 530 | 5,857 | 224,938 | 225.5 K to 224.9 K (-0.24 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.11 | 13,492 | 149,896 | 225,468 | 239 K to 225.5 K (-5.65 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 11.36 | 2,995 | 34,023 | 781,778 | 784.8 K to 781.8 K (-0.38 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 11.36 | 2,995 | 34,023 | 781,778 | 784.8 K to 781.8 K (-0.38 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 11.32 | 1,381 | 15,633 | 238,960 | 240.3 K to 239 K (-0.57 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.41 | 6,800 | 77,588 | 2,719,351 | 2.7 M to 2.7 M (-0.25 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.41 | 6,800 | 77,588 | 2,719,351 | 2.7 M to 2.7 M (-0.25 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 12.03 | 8,563 | 103,013 | 240,341 | 248.9 K to 240.3 K (-3.44 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 12.05 | 10,557 | 127,212 | 784,773 | 795.3 K to 784.8 K (-1.33 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 12.03 | 22,905 | 275,547 | 2,726,151 | 2.7 M to 2.7 M (-0.83 %) |
| Feb 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.98 | 34,132 | 374,769 | 2,749,056 | 2.8 M to 2.7 M (-1.23 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 13,607 | 0 | 795,330 | 781.7 K to 795.3 K (+1.74 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 135,071 | 0 | 781,723 | 646.7 K to 781.7 K (+20.89 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 17,009 | 0 | 2,783,188 | 2.8 M to 2.8 M (+0.61 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 284,748 | 0 | 2,766,179 | 2.5 M to 2.8 M (+11.48 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 9,009 | 0 | 248,904 | 239.9 K to 248.9 K (+3.76 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 69,550 | 0 | 239,895 | 170.3 K to 239.9 K (+40.83 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 15,000 | 0 | 170,345 | 155.3 K to 170.3 K (+9.66 %) |
| Jan 11 2019 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 10.15 | 13,547 | 137,502 | 646,652 | 660.2 K to 646.7 K (-2.05 %) |
| Nov 30 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 11.85 | 26,296 | 311,608 | 659,738 | 686 K to 659.7 K (-3.83 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 175,000 | 0 | 686,034 | 511 K to 686 K (+34.24 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 511,034 | 411 K to 511 K (+24.33 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 2,481,431 | 2.3 M to 2.5 M (+8.77 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 125,000 | 0 | 2,281,431 | 2.2 M to 2.3 M (+5.80 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Grant | A | 0.00 | 13,158 | 0 | 45,121 | 32 K to 45.1 K (+41.17 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Sard Mark | Director | Grant | A | 0.00 | 20,468 | 0 | 36,468 | 16 K to 36.5 K (+127.93 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | HUME DANIEL | Director | Grant | A | 0.00 | 20,468 | 0 | 20,468 | 0 to 20.5 K |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Grant | A | 0.00 | 13,158 | 0 | 28,158 | 15 K to 28.2 K (+87.72 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Cline Darren S | Director | Grant | A | 0.00 | 20,468 | 0 | 20,468 | 0 to 20.5 K |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Grant | A | 0.00 | 13,158 | 0 | 40,443 | 27.3 K to 40.4 K (+48.22 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | ZUERBLIS KENNETH J | Director | Grant | A | 0.00 | 13,158 | 0 | 45,121 | 32 K to 45.1 K (+41.17 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Sard Mark | Director | Grant | A | 0.00 | 20,468 | 0 | 36,468 | 16 K to 36.5 K (+127.93 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | HUME DANIEL | Director | Grant | A | 0.00 | 20,468 | 0 | 20,468 | 0 to 20.5 K |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Forman Alan S | Director | Grant | A | 0.00 | 13,158 | 0 | 28,158 | 15 K to 28.2 K (+87.72 %) |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | Cline Darren S | Director | Grant | A | 0.00 | 20,468 | 0 | 20,468 | 0 to 20.5 K |
| Jun 22 2018 | STML | STEMLINE THERAPEUT ... | BENTSUR RON | Director | Grant | A | 0.00 | 13,158 | 0 | 40,443 | 27.3 K to 40.4 K (+48.22 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 18.28 | 1,525 | 27,877 | 180,684 | 182.2 K to 180.7 K (-0.84 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.20 | 7,658 | 131,718 | 182,209 | 189.9 K to 182.2 K (-4.03 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 16.82 | 12,746 | 214,388 | 409,594 | 422.3 K to 409.6 K (-3.02 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 18.24 | 3,299 | 60,174 | 422,340 | 425.6 K to 422.3 K (-0.78 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 17.18 | 13,942 | 239,524 | 425,639 | 439.6 K to 425.6 K (-3.17 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 18.17 | 6,117 | 111,146 | 2,156,431 | 2.2 M to 2.2 M (-0.28 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.18 | 31,740 | 545,293 | 2,162,548 | 2.2 M to 2.2 M (-1.45 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Grant | A | 0.00 | 70,303 | 0 | 439,581 | 369.3 K to 439.6 K (+19.04 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Hoberman Kenneth | Chief Operating Off ... | Sell | S | 16.55 | 3,027 | 50,097 | 369,278 | 372.3 K to 369.3 K (-0.81 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Grant | A | 0.00 | 37,592 | 0 | 189,867 | 152.3 K to 189.9 K (+24.69 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 16.56 | 1,413 | 23,399 | 152,275 | 153.7 K to 152.3 K (-0.92 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 143,708 | 0 | 2,194,288 | 2.1 M to 2.2 M (+7.01 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 16.56 | 6,797 | 112,558 | 2,050,580 | 2.1 M to 2.1 M (-0.33 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.26 | 13,407 | 231,405 | 2,057,377 | 2.1 M to 2.1 M (-0.65 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.61 | 10,776 | 189,765 | 2,070,784 | 2.1 M to 2.1 M (-0.52 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Gionco David | Chief Accounting Of ... | Sell | S | 17.26 | 4,584 | 79,120 | 153,554 | 158.1 K to 153.6 K (-2.90 %) |